Related Experiment Video
Updated: Jul 12, 2025
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.6K
Proteolytic signaling in cancer
Murilo Salardani1, Uilla Barcick1, André Zelanis1
1Functional Proteomics Laboratory, Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, SP, Brazil.
Expert Review of Proteomics
|October 24, 2023
Summary
Identifying protein fragments from proteolytic processing in cancer can reveal protease roles and substrate functions. This aids in discovering biomarkers for cancer diagnosis, prognosis, and targeted therapies.
Area of Science:
- Oncology
- Proteomics
- Molecular Biology
Background:
- Cancer is a complex disease driven by altered biological pathways and somatic mutations.
- Omics approaches, particularly proteomics, are increasingly contributing to cancer research.
- Proteolytic processing generates protein fragments that offer insights into oncogenesis.
Purpose of the Study:
- To explore the role of proteolytic events in cancer hallmarks like migration, proliferation, angiogenesis, and metastasis.
- To discuss biomarker discovery through proteomics for identifying proteolytic signaling events.
- To understand the implications of protein fragment analysis for cancer diagnosis, prognosis, and targeted therapies.
Main Methods:
- Proteomics mapping of protein fragments.
- Analysis of proteolytic processing events during oncogenesis.
- Integration of omics data for deconvolution of proteolytic signaling.
Main Results:
- Proteolytic processing provides insights into active protease roles and functional implications of processed substrates.
- These findings can potentially predict diagnosis and prognosis in cancer patients.
- Understanding proteolytic events contributes to advancements in tumor biology and precision medicine.
Conclusions:
- Proteolytic processing is a critical irreversible protein modification in cancer.
- Studying proteolytic signaling events using proteomics can lead to novel diagnostic and therapeutic strategies.
- This approach supports the development of targeted therapies in precision medicine.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:22Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
01:01Autocrine Signaling
48.1K
Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
48.1K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K